BERKELEY, CA (UroToday.com) - Robot-assisted laparoscopic prostatectomy (RALP) has rapidly overtaken both open and laparoscopic approaches to the surgical management of prostate cancer in the USA.
It is currently estimated that 60 – 70% of all prostatectomies in the USA are performed robotically and they are often touted as improving patient recovery time, postoperative pain, infection rate, and overall being ‘less invasive.’ Despite this aggressive marketing campaign, there is little data to support an overall benefit to the patient in terms of immediate and long-term surgical outcomes, with the probable exception of blood loss and initial hospital stay.[2,3] Recent data has also suggested that RALP may be associated with higher rates of urological complications, such as early postoperative genitourinary complications, incontinence and erectile dysfunction...View or save the full text Mini Review as a .pdf file
A. Ari Hakimi, David M. Faleck, Steven Sobey, Edward Ioffe, Farhang Rabbani, Sherri M. Donat,* and Reza Ghavamian
Departments of Urology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, and *Memorial Sloan-Kettering Cancer Center, New York, NY, USA